, Jinwoo Cho3,4, Yun-Chul Hong5, Yoon-Jung Choi1,6,7
Objectives
This study aimed to estimate all-cause and cause-specific excess mortality in South Korea from 2020 to 2024, including the post-pandemic transition to endemicity after COVID-19 was reclassified in August 2023.
Methods
Monthly mortality data for January 2000–December 2024 were obtained from Statistics Korea. Causes of death were grouped by International Classification of Diseases, 10th Revision codes: infectious diseases (A00–B99), neoplasms (C00–D48), respiratory diseases (J00–J98), and cardiovascular diseases (I00–I99). Excess mortality, defined as the difference between observed and predicted deaths, was estimated using an exponential smoothing model with multiplicative error, a damped additive trend, and multiplicative seasonality, trained on 2000–2019 data.
Results
Over five years, 194,173 excess deaths were identified (+12.8%). Annual excess mortality was modest in 2020 (3,125 deaths, 1.0%), increased sharply in 2022 (70,373 deaths, 23.3%), and remained elevated in 2023–2024 (16.4% and 18.3%). Monthly excess mortality peaked in March 2022 at 17,871 deaths (+66.8%), of which COVID-19 accounted for 47.1%. Infectious disease mortality had the largest relative excess, peaking at +1,424.7% in March 2022, with COVID-19 accounting for 75.8%. Significant excess mortality from infectious diseases persisted throughout 2024. Cardiovascular mortality exceeded expected levels only in March 2022 (+34.6%). Respiratory mortality shifted from a deficit in 2020–2021 to an excess from 2022 onward. Excess mortality from neoplasms remained negligible through 2022 but increased in 2023–2024.
Conclusions
The pandemic caused substantial excess mortality in South Korea, concentrated in 2022 and driven mainly by infectious diseases; the peak occurred later than in most high-income countries. The persistence of excess mortality into 2023 and 2024, beyond COVID-19 reclassification, indicates that sustained cause-specific surveillance should remain a public health priority.